Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

Healthcare Drug Manufacturers - Specialty & Generic
"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

MERUS LABS INTERNATIONAL INC > the rise in the can dollar
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by curiousbuildon Sep 03, 2015 4:49pm
86 Views
Post# 24076882

RE:RE:RE: the rise in the can dollar

RE:RE:RE: the rise in the can dollarThere is no point of focusing on forex as nobody knows where it will go, especially daily rate changes.. plus, forex rates may remain same for years to come, let alone quarter or two..

 Company's execution is more important than forex to me.. 

CB 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities